Caribou Biosciences, Inc.
CRBU
$1.34
$0.064.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.68% | -2.32% | 7.99% | 8.58% | -19.50% |
| Total Depreciation and Amortization | -1.60% | 0.59% | 37.50% | 20.56% | -4.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.63% | -14.50% | 229.44% | -73.29% | -43.36% |
| Change in Net Operating Assets | 65.23% | -52.34% | -198.71% | 436.98% | -116.90% |
| Cash from Operations | -3.54% | -8.60% | 0.62% | 11.66% | -74.02% |
| Capital Expenditure | -101.16% | 23.03% | 69.97% | -54.77% | 36.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 206.80% | -39.56% | 16.01% | -3.95% | 183.58% |
| Cash from Investing | 209.99% | -39.93% | 25.10% | -7.65% | 172.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.89% | 1,483.20% | 84.85% | -98.94% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -87.89% | 1,483.20% | 84.85% | -98.94% | 29,134.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 183.71% | -165.89% | 48.88% | -554.60% | 96.67% |